L2.5 (Letrozole 2.5 mg)
Pill with imprint L2.5 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Aurobindo Pharma Limited.
Letrozole is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for L2.5
Letrozole
- Imprint
- L2.5
- Strength
- 2.5 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Aromatase inhibitors, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma Limited
- Manufacturer
- Sun Pharmaceutical Industries Ltd.
- National Drug Code (NDC)
- 59651-0180
Related Images for "L2.5"
More about letrozole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 231 Reviews
- Drug class: aromatase inhibitors
Consumer resources
- Other brands
- Femara
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.